A new approach to block
vascular-mediated inflammation
Therini Bio is developing pioneering therapies based on world-class science to halt chronic neuro
We are advancing a novel, clinical-stage pipeline focused on selectively targeting toxic fibrin deposits that trigger inflammation cascades and underlie numerous diseases, including Alzheimer’s Disease and Diabetic Macular Edema.
Our experienced team is dedicated to efficiently progressing our candidates through the clinic to potentially improve the lives of people suffering from neuro
We are backed by a top-tier syndicate of investors in life sciences and neuro
